FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1539774679> ?p ?o ?g. }

• W1539774679 endingPage "561" @default.
• W1539774679 startingPage "555" @default.
• W1539774679 abstract "Abstract Therapy of chronic graft-v-host disease (GVHD) has been unsatisfactory in patients with platelet counts less than 100,000/microL. Survival at 5 years after marrow transplant is only 26% in such patients treated with trimethoprim-sulfamethoxazole (TMP-SMX) and every other day with prednisone. Since October 1982, 61 patients with high-risk extensive chronic GVHD were treated with a new alternating-day regimen of prednisone (1 mg/kg every other day) and oral cyclosporine (6 mg/kg every 12 hours every other day) with one double-strength TMP-SMX tablet twice daily. Forty patients (group I) received primary treatment of thrombocytopenic chronic GVHD (median platelet count 35 [range 7 to 87] x 10(3)/microL). Twenty-one patients (group II) received salvage treatment after failing initial prednisone +/- azathioprine. Twenty-one patients in group I and 15 in group II survive with a minimum of 2 years and a median of 3.7 years follow-up. At 4 years after transplant, actuarial survival is 51% (group I) and 67% (group II). Causes of death included interstitial pneumonia (six), relapse (five), GVHD without infection (five), infection (four), organ failure (three), and hemorrhage (two). Mortality increased with the progressive type onset of chronic GVHD and treatment failure. Toxicity included hypertension (13), nephrotoxicity (nine), nausea (seven), aseptic necrosis (five), neurologic abnormalities (four), and diabetes (three). Median cyclosporine levels at four and 36 hours were 296 and 64 ng/mL, respectively. Four patients required permanent discontinuation of cyclosporine, but none required renal dialysis. Karnofsky performance scores for 25 survivors are 90% to 100%, scores for six survivors are 70% to 89%, and scores for five survivors are less than 70%. Alternating-day cyclosporine and prednisone has acceptable toxicity and appears to improve survival in patients with high-risk chronic GVHD." @default.
• W1539774679 created "2016-06-24" @default.
• W1539774679 creator A5010962133 @default.
• W1539774679 creator A5019136314 @default.
• W1539774679 creator A5028999351 @default.
• W1539774679 creator A5031499863 @default.
• W1539774679 creator A5032751122 @default.
• W1539774679 creator A5038311224 @default.
• W1539774679 creator A5059666930 @default.
• W1539774679 creator A5060323697 @default.
• W1539774679 creator A5060783496 @default.
• W1539774679 creator A5085787488 @default.
• W1539774679 date "1988-08-01" @default.
• W1539774679 modified "2023-10-03" @default.
• W1539774679 title "Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease" @default.
• W1539774679 cites W107728909 @default.
• W1539774679 cites W1530764705 @default.
• W1539774679 cites W1562876511 @default.
• W1539774679 cites W1596160021 @default.
• W1539774679 cites W1597544321 @default.
• W1539774679 cites W168192535 @default.
• W1539774679 cites W1944382470 @default.
• W1539774679 cites W1964160654 @default.
• W1539774679 cites W1979300931 @default.
• W1539774679 cites W1987759419 @default.
• W1539774679 cites W1991972231 @default.
• W1539774679 cites W1993519091 @default.
• W1539774679 cites W1996762936 @default.
• W1539774679 cites W2018535826 @default.
• W1539774679 cites W2026451853 @default.
• W1539774679 cites W2053278212 @default.
• W1539774679 cites W2056339523 @default.
• W1539774679 cites W2067480394 @default.
• W1539774679 cites W2073993963 @default.
• W1539774679 cites W2112486596 @default.
• W1539774679 cites W2115232902 @default.
• W1539774679 cites W2139984188 @default.
• W1539774679 cites W2194721788 @default.
• W1539774679 cites W2291925789 @default.
• W1539774679 cites W2317642686 @default.
• W1539774679 cites W2336806052 @default.
• W1539774679 cites W2337814216 @default.
• W1539774679 cites W2337969406 @default.
• W1539774679 cites W2339383437 @default.
• W1539774679 cites W2369152357 @default.
• W1539774679 cites W2396957136 @default.
• W1539774679 cites W2399735063 @default.
• W1539774679 cites W2411408157 @default.
• W1539774679 cites W2411673935 @default.
• W1539774679 cites W2417570445 @default.
• W1539774679 cites W2420275041 @default.
• W1539774679 cites W2429002031 @default.
• W1539774679 cites W2437155500 @default.
• W1539774679 cites W307132063 @default.
• W1539774679 cites W2166379268 @default.
• W1539774679 doi "https://doi.org/10.1182/blood.v72.2.555.555" @default.
• W1539774679 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3042042" @default.
• W1539774679 hasPublicationYear "1988" @default.
• W1539774679 type Work @default.
• W1539774679 sameAs 1539774679 @default.
• W1539774679 citedByCount "277" @default.
• W1539774679 countsByYear W15397746792012 @default.
• W1539774679 countsByYear W15397746792013 @default.
• W1539774679 countsByYear W15397746792014 @default.
• W1539774679 countsByYear W15397746792015 @default.
• W1539774679 countsByYear W15397746792016 @default.
• W1539774679 countsByYear W15397746792017 @default.
• W1539774679 countsByYear W15397746792018 @default.
• W1539774679 countsByYear W15397746792019 @default.
• W1539774679 countsByYear W15397746792020 @default.
• W1539774679 countsByYear W15397746792021 @default.
• W1539774679 countsByYear W15397746792022 @default.
• W1539774679 countsByYear W15397746792023 @default.
• W1539774679 crossrefType "journal-article" @default.
• W1539774679 hasAuthorship W1539774679A5010962133 @default.
• W1539774679 hasAuthorship W1539774679A5019136314 @default.
• W1539774679 hasAuthorship W1539774679A5028999351 @default.
• W1539774679 hasAuthorship W1539774679A5031499863 @default.
• W1539774679 hasAuthorship W1539774679A5032751122 @default.
• W1539774679 hasAuthorship W1539774679A5038311224 @default.
• W1539774679 hasAuthorship W1539774679A5059666930 @default.
• W1539774679 hasAuthorship W1539774679A5060323697 @default.
• W1539774679 hasAuthorship W1539774679A5060783496 @default.
• W1539774679 hasAuthorship W1539774679A5085787488 @default.
• W1539774679 hasBestOaLocation W15397746791 @default.
• W1539774679 hasConcept C126322002 @default.
• W1539774679 hasConcept C141071460 @default.
• W1539774679 hasConcept C2776760755 @default.
• W1539774679 hasConcept C2778715236 @default.
• W1539774679 hasConcept C2778720950 @default.
• W1539774679 hasConcept C2779134260 @default.
• W1539774679 hasConcept C2779972918 @default.
• W1539774679 hasConcept C2779978075 @default.
• W1539774679 hasConcept C2781413609 @default.
• W1539774679 hasConcept C2911091166 @default.
• W1539774679 hasConcept C71924100 @default.
• W1539774679 hasConcept C90924648 @default.
• W1539774679 hasConceptScore W1539774679C126322002 @default.

• next